Mahajan Sonia, Barker Christopher A, Singh Bhuvanesh, Pandit-Taskar Neeta
Departments of Radiology.
Radiation Oncology.
Nucl Med Commun. 2019 Jul;40(7):744-751. doi: 10.1097/MNM.0000000000001029.
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin malignancy. Computed tomography (CT) and/or MRI are commonly used for staging, however, the role of fluorine-18-fluorodeoxyglucose (F-FDG)-PET is not clearly established. In this study, we evaluated F-FDG-PET/CT imaging for initial staging of cSCC.
F-FDG-PET/CT scans performed in patients with newly diagnosed cSCC were reviewed retrospectively. Images were visually assessed for lesions and F-FDG uptake [standardized uptake value (SUV)] in primary and secondary sites was measured. Suspected lesions on F-FDG-PET/CT were correlated with histopathology when available, follow-up imaging or clinical data in others.
Twenty-three cSCC patients who underwent F-FDG-PET/CT at diagnosis were evaluated. Primary sites were in head/neck (n=21), chest (n=1), and foot (n=1). All patients had F-FDG-positive scans with a total of 51 F-FDG-positive lesions. All primary lesions (n=24) were F-FDG-positive (SUV: 2.3-22.8; mean 10.2), and additional 27 F-FDG-positive lesions, including 21 nodes, four cutaneous, one osseous and one lung lesion, were noted in 13 patients. Mean size of F-FDG-positive nodes was 0.9 cm (range: 0.4-2.5 cm), predominantly clinically impalpable. Pathology was available for 40/51 lesions; 31 sites positive for malignancy. SUV (mean±SD) was 9.2±6.2 for malignant and 2.7±1.2 for benign lesions. Sensitivity, positive predictive value, and accuracy of F-FDG-PET/CT scan were 100, 77.5, and 77.5%, respectively. F-FDG detected seven additional lesions in three patients, compared to CT/MRI. Overall, staging F-FDG-PET/CT detected nine prior unknown lesions in five patients that were proven metastatic disease by histopathology or follow-up; F-FDG-PET/CT modified management in 5/23 (21.7%) patients.
F-FDG-PET/CT has high sensitivity in the detection of cSCC lesions, including small cutaneous and nodal disease, and has a potential role in initial staging and management.
皮肤鳞状细胞癌(cSCC)是第二常见的皮肤恶性肿瘤。计算机断层扫描(CT)和/或磁共振成像(MRI)常用于分期,然而,氟-18-氟脱氧葡萄糖(F-FDG)-PET的作用尚未明确确立。在本研究中,我们评估了F-FDG-PET/CT成像在cSCC初始分期中的应用。
回顾性分析新诊断为cSCC患者的F-FDG-PET/CT扫描结果。对图像进行视觉评估以观察病变,并测量原发和继发部位的F-FDG摄取[标准化摄取值(SUV)]。F-FDG-PET/CT上可疑病变若有组织病理学结果则与之关联,其他情况则与随访影像或临床数据关联。
评估了23例诊断时接受F-FDG-PET/CT检查的cSCC患者。原发部位在头颈部(n = 21)、胸部(n = 1)和足部(n = 1)。所有患者的扫描结果均为F-FDG阳性,共有51个F-FDG阳性病变。所有原发病变(n = 24)均为F-FDG阳性(SUV:2.3 - 22.8;平均10.2),13例患者中还发现了另外27个F-FDG阳性病变,包括21个淋巴结、4个皮肤病变、1个骨病变和1个肺部病变。F-FDG阳性淋巴结的平均大小为0.9 cm(范围:0.4 - 2.5 cm),主要为临床触诊不可及。51个病变中有40个有病理结果;31个部位为恶性。恶性病变的SUV(平均值±标准差)为9.2±6.2,良性病变为2.7±1.2。F-FDG-PET/CT扫描的敏感性、阳性预测值和准确性分别为100%、77.5%和77.5%。与CT/MRI相比,F-FDG在3例患者中检测到另外7个病变。总体而言,F-FDG-PET/CT分期在5例患者中检测到9个先前未知的病变,经组织病理学或随访证实为转移性疾病;F-FDG-PET/CT改变了23例患者中5例(21.7%)的治疗方案。
F-FDG-PET/CT在检测cSCC病变方面具有高敏感性,包括小的皮肤和淋巴结病变,在初始分期和治疗中具有潜在作用。